Literature DB >> 30382957

Large artery stiffness is associated with marinobufagenin in young adults: the African-PREDICT study.

Michél Strauss1, Wayne Smith1,2, Wen Wei3, Alexei Y Bagrov3, Olga V Fedorova3, Aletta E Schutte1,2.   

Abstract

OBJECTIVES: The cardiotonic steroid, marinobufagenin (MBG), has been shown to play a physiological natriuretic role in response to salt intake. However, recent studies in clinical and animal models demonstrated possible links between elevated levels of endogenous MBG and increased arterial stiffness. Large artery stiffness is a known predictor of future cardiovascular disease. We, therefore, investigated whether large artery stiffness relates to 24-h urinary MBG excretion in young apparently healthy black and white adults.
METHODS: This study included data of 711 participants (black 51%, men 42%, mean age 24.8 ± 3.02 years). We measured the carotid-femoral pulse wave velocity (cfPWV), 24-h urinary MBG and sodium excretion.
RESULTS: In single, partial and multivariable adjusted (Adj.) regression analyses, we found a persistent positive association between cfPWV and MBG excretion in women [Adj. R = 0.23; standardized (std.) β = 0.15; P = 0.002], but not men (Adj. R = 0.17; std. β = 0.06; P = 0.31). Multiple regression models were adjusted for ethnicity, age, waist-to-height ratio, mean arterial pressure, high-density lipoprotein cholesterol, C-reactive protein, γ-glutamyl transferase and glucose.
CONCLUSION: In conclusion, already at a young age heightened endogenous MBG levels may contribute to large artery stiffness in women via pressure-independent mechanisms, increasing their risk for future cardiovascular disease.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30382957      PMCID: PMC6329631          DOI: 10.1097/HJH.0000000000001866

Source DB:  PubMed          Journal:  J Hypertens        ISSN: 0263-6352            Impact factor:   4.844


  23 in total

Review 1.  Prediction of cardiovascular events and all-cause mortality with arterial stiffness: a systematic review and meta-analysis.

Authors:  Charalambos Vlachopoulos; Konstantinos Aznaouridis; Christodoulos Stefanadis
Journal:  J Am Coll Cardiol       Date:  2010-03-30       Impact factor: 24.094

2.  Gender difference in rat aorta vasodilation after acute exposure to high glucose: involvement of protein kinase C beta and superoxide but not of Rho kinase.

Authors:  Aditya Goel; Yingmin Zhang; Leigh Anderson; Roshanak Rahimian
Journal:  Cardiovasc Res       Date:  2007-07-04       Impact factor: 10.787

3.  Marinobufagenin stimulates fibroblast collagen production and causes fibrosis in experimental uremic cardiomyopathy.

Authors:  Jihad Elkareh; David J Kennedy; Belvadi Yashaswi; Sandeep Vetteth; Amjad Shidyak; Eric G R Kim; Sleiman Smaili; Sankaridrug M Periyasamy; Imad M Hariri; Larisa Fedorova; Jiang Liu; Liang Wu; M Bashar Kahaleh; Zijian Xie; Deepak Malhotra; Olga V Fedorova; Vladimir A Kashkin; Alexei Y Bagrov; Joseph I Shapiro
Journal:  Hypertension       Date:  2006-12-04       Impact factor: 10.190

4.  Marinobufagenin-induced vascular fibrosis is a likely target for mineralocorticoid antagonists.

Authors:  Olga V Fedorova; Igor V Emelianov; Konstantin A Bagrov; Yulia N Grigorova; Wen Wei; Ondrej Juhasz; Elena V Frolova; Courtney A Marshall; Edward G Lakatta; Alexandra O Konradi; Alexei Y Bagrov
Journal:  J Hypertens       Date:  2015-08       Impact factor: 4.844

5.  Endogenous Na,K pump ligands are differentially regulated during acute NaCl loading of Dahl rats.

Authors:  O V Fedorova; E G Lakatta; A Y Bagrov
Journal:  Circulation       Date:  2000-12-12       Impact factor: 29.690

6.  Endogenous sodium pump inhibitors and age-associated increases in salt sensitivity of blood pressure in normotensives.

Authors:  David E Anderson; Olga V Fedorova; Christopher H Morrell; Dan L Longo; Vladimir A Kashkin; Jessica D Metzler; Alexei Y Bagrov; Edward G Lakatta
Journal:  Am J Physiol Regul Integr Comp Physiol       Date:  2008-02-20       Impact factor: 3.619

7.  Marinobufagenin induces increases in procollagen expression in a process involving protein kinase C and Fli-1: implications for uremic cardiomyopathy.

Authors:  Jihad Elkareh; Sankaridrug M Periyasamy; Amjad Shidyak; Sandeep Vetteth; Jeremy Schroeder; Vanamala Raju; Imad M Hariri; Nasser El-Okdi; Shalini Gupta; Larisa Fedorova; Jiang Liu; Olga V Fedorova; M Bashar Kahaleh; Zijian Xie; Deepak Malhotra; Dennis K Watson; Alexei Y Bagrov; Joseph I Shapiro
Journal:  Am J Physiol Renal Physiol       Date:  2009-03-04

8.  Dietary sodium restriction and association with urinary marinobufagenin, blood pressure, and aortic stiffness.

Authors:  Kristen L Jablonski; Olga V Fedorova; Matthew L Racine; Candace J Geolfos; Phillip E Gates; Michel Chonchol; Bradley S Fleenor; Edward G Lakatta; Alexei Y Bagrov; Douglas R Seals
Journal:  Clin J Am Soc Nephrol       Date:  2013-08-08       Impact factor: 8.237

9.  European Society of Hypertension practice guidelines for ambulatory blood pressure monitoring.

Authors:  Gianfranco Parati; George Stergiou; Eoin O'Brien; Roland Asmar; Lawrence Beilin; Grzegorz Bilo; Denis Clement; Alejandro de la Sierra; Peter de Leeuw; Eamon Dolan; Robert Fagard; John Graves; Geoffrey A Head; Yutaka Imai; Kazuomi Kario; Empar Lurbe; Jean-Michel Mallion; Giuseppe Mancia; Thomas Mengden; Martin Myers; Gbenga Ogedegbe; Takayoshi Ohkubo; Stefano Omboni; Paolo Palatini; Josep Redon; Luis M Ruilope; Andrew Shennan; Jan A Staessen; Gert vanMontfrans; Paolo Verdecchia; Bernard Waeber; Jiguang Wang; Alberto Zanchetti; Yuqing Zhang
Journal:  J Hypertens       Date:  2014-07       Impact factor: 4.844

10.  Monoclonal antibody to an endogenous bufadienolide, marinobufagenin, reverses preeclampsia-induced Na/K-ATPase inhibition and lowers blood pressure in NaCl-sensitive hypertension.

Authors:  Olga V Fedorova; Andrey S Simbirtsev; Nikolai I Kolodkin; Alexander Y Kotov; Natalia I Agalakova; Vladimir A Kashkin; Natalia I Tapilskaya; Anton Bzhelyansky; Vitaly A Reznik; Elena V Frolova; Elena R Nikitina; Georgy V Budny; Dan L Longo; Edward G Lakatta; Alexei Y Bagrov
Journal:  J Hypertens       Date:  2008-12       Impact factor: 4.844

View more
  10 in total

1.  Cardiotonic Steroids Induce Vascular Fibrosis Via Pressure-Independent Mechanism in NaCl-Loaded Diabetic Rats.

Authors:  Olga V Fedorova; Artem V Fadeev; Yulia N Grigorova; Courtney A Marshall; Valentina Zernetkina; Nikolai I Kolodkin; Natalia I Agalakova; Alexandra O Konradi; Edward G Lakatta; Alexei Y Bagrov
Journal:  J Cardiovasc Pharmacol       Date:  2019-11       Impact factor: 3.105

2.  Effect of Cardiotonic Steroid Marinobufagenin on Vascular Remodeling and Cognitive Impairment in Young Dahl-S Rats.

Authors:  Yulia N Grigorova; Ondrej Juhasz; Jeffrey M Long; Valentina I Zernetkina; Mikayla L Hall; Wen Wei; Christopher H Morrell; Natalia Petrashevskaya; Audrey Morrow; Katherine H LaNasa; Alexei Y Bagrov; Peter R Rapp; Edward G Lakatta; Olga V Fedorova
Journal:  Int J Mol Sci       Date:  2022-04-20       Impact factor: 6.208

Review 3.  The Na+K+-ATPase Inhibitor Marinobufagenin and Early Cardiovascular Risk in Humans: a Review of Recent Evidence.

Authors:  Michél Strauss; Wayne Smith; Olga V Fedorova; Aletta E Schutte
Journal:  Curr Hypertens Rep       Date:  2019-04-12       Impact factor: 5.369

4.  Autonomic activity and its relationship with the endogenous cardiotonic steroid marinobufagenin: the African-PREDICT study.

Authors:  Michél Strauss; Wayne Smith; Wen Wei; Olga V Fedorova; Aletta E Schutte
Journal:  Nutr Neurosci       Date:  2019-01-07       Impact factor: 4.994

5.  Microvascular function in non-dippers: Potential involvement of the salt sensitivity biomarker, marinobufagenin-The African-PREDICT study.

Authors:  Michél Strauss-Kruger; Wayne Smith; Wen Wei; Alexei Y Bagrov; Olga V Fedorova; Aletta E Schutte
Journal:  J Clin Hypertens (Greenwich)       Date:  2019-12-24       Impact factor: 2.885

6.  Monoclonal Antibody to Marinobufagenin Downregulates TGFβ Profibrotic Signaling in Left Ventricle and Kidney and Reduces Tissue Remodeling in Salt-Sensitive Hypertension.

Authors:  Yongqing Zhang; Wen Wei; Victoria Shilova; Natalia N Petrashevskaya; Valentina I Zernetkina; Yulia N Grigorova; Courtney A Marshall; Rachel C Fenner; Elin Lehrmann; William H Wood; Kevin G Becker; Edward G Lakatta; Alexei Y Bagrov; Olga V Fedorova
Journal:  J Am Heart Assoc       Date:  2019-10-02       Impact factor: 6.106

7.  The African Prospective study on the Early Detection and Identification of Cardiovascular disease and Hypertension (African-PREDICT): Design, recruitment and initial examination.

Authors:  Aletta E Schutte; Philimon N Gona; Christian Delles; Aletta S Uys; Adele Burger; Catharina Mc Mels; Ruan Kruger; Wayne Smith; Carla Mt Fourie; Shani Botha; Leandi Lammertyn; Johannes M van Rooyen; Lebo F Gafane-Matemane; Gontse G Mokwatsi; Yolandi Breet; H Salome Kruger; Tertia van Zyl; Marlien Pieters; Lizelle Zandberg; Roan Louw; Sarah J Moss; Itumeleng P Khumalo; Hugo W Huisman
Journal:  Eur J Prev Cardiol       Date:  2019-01-06       Impact factor: 7.804

Review 8.  Cardiotonic Steroids-A Possible Link Between High-Salt Diet and Organ Damage.

Authors:  Aneta Paczula; Andrzej Wiecek; Grzegorz Piecha
Journal:  Int J Mol Sci       Date:  2019-01-30       Impact factor: 5.923

9.  The Cardiotonic Steroid Marinobufagenin Is a Predictor of Increased Left Ventricular Mass in Obesity: The African-PREDICT Study.

Authors:  Michél Strauss-Kruger; Ruan Kruger; Wayne Smith; Lebo F Gafane-Matemane; Gontse Mokwatsi; Wen Wei; Olga V Fedorova; Aletta E Schutte
Journal:  Nutrients       Date:  2020-10-18       Impact factor: 5.717

10.  Canrenone Restores Vasorelaxation Impaired by Marinobufagenin in Human Preeclampsia.

Authors:  Natalia I Agalakova; Yulia N Grigorova; Ivan A Ershov; Vitaly A Reznik; Elena V Mikhailova; Olga V Nadei; Leticia Samuilovskaya; Larisa A Romanova; C David Adair; Irina V Romanova; Alexei Y Bagrov
Journal:  Int J Mol Sci       Date:  2022-03-19       Impact factor: 5.923

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.